US5171251003

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreichs Ataxia

June 26, 2026 16:05 ET  | Source: Larimar Therapeutics Webcast on Monday, June 29, 2026, at 7:45 am ET BALA…

4 hours ago